Program

Download the short program
here;
and the complete program (including abstracts)
here.
The program and all the information around the conference is now available for mobile devices (Apple Store and Google Play for Android).
Please follow this
link or use the QR code.
| Monday | Tuesday | Wednesday |
Monday, 12 September
| 10:00 – 11:00 | Registration |
| Lecture hall F |
Opening |
| 11:00 – 11:10 | Welcome to Hannover Medical School (MHH) Christopher Baum, President, Hannover Medical School |
| 11:10 – 11:20 | Welcome to Hannover and Lower Saxony MPräs. Stephan Weil (Minister-President of Lower Saxony) |
| 11:20 – 11:30 | Ulrich Martin, Acting President, GSCN |
| 11:30 – 12:15 |
Keynote lecture I K1 – Mechanisms of epigenetic regulation in stem cells and development Alexander Meissner, Harvard University, Cambridge, U.S.A. (Chair: Ulrich Martin) |
| 12:15 – 13:00 | Keynote lecture II K2 – Identification of niches for hematopoietic stem cells and osteogenesis Sean Morrison, UT Southwestern, Dallas, U.S.A. (Chair: Claudia Waskow) |
| 13:00 – 14:00 |
Lunch break / Industry exhibition |
| Concurrent scientific working group session I |
|
| Lecture hall H |
Stem cells in regenerative therapies I (Chairs: Wolfgang Wagner/Ulrich Martin) |
| 14:00 – 14:15 |
Overview Wolfgang Wagner, RWTH Aachen |
| 14:15 – 14:30 |
T01 – HLA-silenced platelets derived from induced pluripotent stem cells are protected against refractoriness in a platelet transfusion mouse model Dorothee Eicke, Hannover Medical School |
| 14:30 – 14:45 |
T02 – Immunogenicity of embryonic stem cell-derived cardiomyocytes in recipients mismatched for minor and major histocompatibility antigens Birte Baudis, University of Cologne |
| 14:45 – 15:00 |
T03 – BSA-free differentiation of hPSCs into cardiomyocytes Hanna Möller, Hannover Medical School |
| 15:00 – 15:15 |
T04 – A registry of pluripotent stem cells for clinical application Andreas Kurtz, Berlin-Brandenburg Center for Regenerative Therapies, Charité, Berlin |
| 15:15 – 15:30 |
Working group discussion |
| Lecture hall G | Pluripotency and reprograming (Chairs: Micha Drukker/Mathias Treier) |
| 14:00 – 14:25 |
T05 – Pluripotency keynote – Trophoblast stem cells from murine fibroblasts – can the mouse serve as blueprint for the human situation? Hubert Schorle, University of Bonn |
| 14:25 – 14:40 |
T06 – Nanotopography guides morphology and spatial patterning of induced pluripotent stem cell colonies Giulio Abagnale, RWTH Aachen |
| 14:40 – 14:55 |
T07 – Propagation of the early murine inner cell mass state in cell culture Xiushan Yin, Max Delbrück Center, Berlin |
| 14:55 – 15:10 |
T08 – Contribution of cynomolgus monkey induced pluripotent stem cells to porcine embryos Monika Nowak-Imialek, Friedrich Loeffler Institute, Mariensee |
| 15:10 – 15:25 |
T09 – Characterization and potential immunomodulatory properties of human induced pluripotent stem cell (hiPSC)-derived trophoblast cells Svitlana Malysheva, Hannover Medical School |
| 15:25 – 15:30 |
Working group discussion |
| Lecture hall M | Hematopoietic stem cells (Chairs: Timm Schröder/Claudia Waskow) |
| 14:00 – 14:25 |
T10 – HSC keynote – Hematopoietic stem cell fate realized in vivo Hans-Reimer Rodewald, German Cancer Research Center, Heidelberg |
| 14:25 – 14:40 |
T11 – The bulk of the hematopoietic stem cell population is dispensable for murine steady-state and stress hematopoiesis Kristina Schödel, TU Dresden |
| 14:40 – 14:55 |
T12 – Heterogeneity and in vivo regulation of dormant hematopoietic stem cells Nina Cabezas-Wallscheid, German Cancer Research Center, Heidelberg |
| 14:55 – 15:10 |
T13 – Essential role for Setd1a-mediated histone methylation in adult hematopoietic stem cell function Kathrin Arndt, TU Dresden |
| 15:10 – 15:25 |
T14 – Biomimetic bone marrow analogs as artifical hematopoietic stem cell niches Cornelia Lee-Thedieck, Karlsruhe Institute of Technology |
| 15:25 – 15:30 |
Working group discussion |
| Lecture hall N |
Tissue engineering and organoids (Chairs: Robert Zweigerdt/Benedikt Berninger) |
| 14:00 – 14:30 |
Overview Robert Zweigerdt, Hannover Medical School Benedikt Berninger, University Medical Center, Mainz |
| 14:30 – 14:45 |
T15 – Stirred suspension culture for the scalable generation of billions of human induced pluripotent stem cells Chee Keong Kwok, University of Würzburg |
| 14:45 – 15:00 |
T16 – Biofabrication of a perfusable 3D liver tissue construct using organoids Kerstin Schneeberger, Utrecht University, Netherlands |
| 15:00 – 15:15 |
T17 – Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modeling Alexander Kleger, University Medical Center, Ulm |
| 15:15 – 15:30 |
T18 – Differentiation of pericytes from hiPSCs for the vascularization of bioartificial cardiac tissues Mónika Szepes, Hannover Medical School |
| 15:30 – 16:00 | Coffee break / Industry exhibition |
| Lecture hall H |
|
| 16:00 – 17:00 |
GSCN General membership meeting |
| 17:00 – 19:00 | Poster session I: P001 – P077 P001 – P017: Pluripotency and reprograming P018 – P039: Somatic stem cells and development P040 – P053: Hematopoietic stem cells P054 – P060: Stems cells and ageing, genome stability and epigenetics P061 – P066: Stem cells in diseases: cancer stem cells P067 – P077: Computational stem cell biology and systems biology Even numbers: please present your poster from 17:00 – 18:00 Odd numbers: 18:00 – 19:00 |
| Lecture hall F | |
| 19:00 – 19:45 |
Keynote lecture III K3 – Generation of human organs in pigs Hiroshi Nagashima, Meiji University, Tokyo, Japan (Chair: Tobias Cantz, in collaboration with ELSI project “induced totipotency”) |
| 19:45 – 21:00 | Informal GSCN Get together for all participants with dinner buffet at the foyer of the MHH |
Top |
Tuesday, 13 September
| Concurrent scientific working group session II |
|
|
| Lecture hall H |
Stem cells in disease modeling and drug development (Chairs: Karl-Ludwig Laugwitz/Oliver Brüstle) | |
| 09:00 – 09:15 | Overview Karl-Ludwig Laugwitz, TU München |
|
| 09:15 – 09:30 | T19 – Stiff matrix induces switch to pure beta-cardiac myosin heavy chain expression in human embryonic stem cell-derived cardiomyocytes Natalia Weber, Hannover Medical School |
|
| 09:30 – 09:45 | T20 – A new model to study neurotoxicity of drug metabolites based on chemical conversion to neurons-on-a-chip in tandem with liver-on-a-chip Xinlai Cheng, Heidelberg University |
|
| 09:45 – 10:00 | T21 – Employing rapid phenotypic assays in SPG4 patient neurons for drug discovery and rescue Kristina Rehbach, University of Bonn |
|
| 10:00 – 10:15 | T22 – Patient-specific iPS cell-based modeling of Transthyretin-Related Familial Amyloid Polyneuropathy Jeannine Hoepfner, Hannover Medical School |
|
| 10:15 – 10:30 | Working group discussion | |
| 10:30 – 11:00 |
Coffee break/industry exhibition |
|
| Lecture hall G | Stem cells and aging, genome stability and epigenetics (Chairs: Hartmut Geiger/Karl Lenhard Rudolph) | |
| 09:00 – 09:15 | Overview Hartmut Geiger, Ulm University |
|
| 09:15 – 09:30 | T23 – Dnmt3b-dependent intragenic DNA methylation prevents RNA Polymerase II spurious entry on gene bodies and cryptic transcription initiations Francesco Neri, Leibniz Institute on Aging, Jena |
|
| 09:30 – 09:45 | T24 – Aging shifts the mode and outcome of the hematopoietic stem cell division M. Carolina Florian, University of Ulm |
|
| 09:45 – 10:00 | T25 – Bone marrow niche and hematopoietic stem cell differentiation are regulated by the microbiota Aline Bozec, University of Erlangen-Nuremberg |
|
| 10:00 – 10:15 | T26 – Restricted regeneration of hematopoietic stem cells in vivo following chronic inflammatory stress Ruzhica Bogeska, German Cancer Reserach Center, Heidelberg |
|
| 10:15 – 10:30 | T27 – Hoxa9 induced developmental signals impair stem cells and regeneration of aging muscle Simon Schwörer, Leibniz Institute on Aging, Jena |
|
| 10:30 – 11:00 |
Coffee break/industry exhibition |
|
| Lecture hall M | Computational stem cell biology and systems biology (Chairs: Georg Fuellen/Ingo Roeder) |
|
| 09:00 – 09:15 | Overview Carsten Marr, Helmholtz Center Munich |
|
| 09:15 – 09:30 | T28 – Scoring cell identity from transcription profiles Nancy Mah, Berlin-Brandenburg Center for Regenerative Therapies, Charite, Berlin |
|
| 09:30 – 09:45 | T29 – Understanding and predicting regulatory mechanisms in early differentiation of human pluripotent stem cells Erika Gaspari, University of Bologna, Italy |
|
| 09:45 – 10:00 | T30 – FGF/MAPK signaling sets the switching threshold of a bistable circuit controling fate decisions in embryonic stem cells Christian Schröter, Max Planck Institute of Molecular Physiology, Dortmund |
|
| 10:00 – 10:15 | T31 – Reconstructing lineage branching from single cell RNA-seq in adult haematopoiesis via diffusion pseudo time Maren Büttner, Helmholtz Center Munich |
|
| 10:15 – 10:30 | Working group discussion | |
| 10:30 – 11:00 |
Coffee break/industry exhibition |
|
| Lecture hall N | Genome engineering and gene therapy (Chairs: Axel Schambach/ Hans Schöler) (in collaboration with ELSI project “induced totipotency”) |
|
| 09:00 – 09:15 | Overview – Germ Cell Differentiation Hans Schöler, MPI f. Molecular Biomedicine, Münster |
|
| 09:15 – 09:30 | Overview – Gene Therapy & Genome Engineering Axel Schambach, Hannover Medical School |
|
| 09:30 – 09:45 | T32 – Designer-nuclease mediated knockout of HIV co-receptor CCR5 – a promising gene-therapy approach to protect T cells from HIV infection Boris Fehse, UKE Hamburg |
|
| 09:45 – 10:00 | T33 – Efficient introduction of homo- and heterozygous mutations with CRISPR/Cas9 and applications to disease modeling in stem cells Dominik Paquet, The Rockefeller University, New York, U.S.A. |
|
| 10:00 – 10:15 | T34 – Efficient and accurate precision genome engineering of transcriptionally silent disease-related loci by CRISPR/Cas9 nickase Reto Eggenschwiler, Hannover Medical School |
|
| 10:15 – 10:30 | T35 – Generation of HLA depleted human pluripotent stem cell lines for modulation of the immunogenicity of iPSC derivatives Lena Engels, Hannover Medical School |
|
| 10:30 – 11:00 |
Coffee break/industry exhibition |
|
| Industry session: “Technologies from GSCN industry partners” | |
|
| Lecture hall H |
Main supporter (Chair: Michael Cross) | |
| 11:00 – 11:05 | Introduction | |
| 11:05 – 11:35 | C1 – Simplified dopaminergic neuron and cardiac differentiation of single episome reprogrammed fibroblasts Rick I. Cohen, Rutgers University, Piscataway, U.S.A., representing PeproTech GmbH |
|
| 11:35 – 12:05 | C2 – Expansion of Human Bone Marrow-Derived Mesenchymal Stem Cells in BioBLU® 0.3c Single-Use Bioreactors Aurélie Tacheny, Eppendorf Application Technologies S.A., Namur, Belgium |
|
| 12:05 – 12:35 | C3 – A novel system to generate HPS cell-derived hepatocytes with potential application to drug discovery and metabolism, and hepatotoxicity studies Barbara Küppers-Munther, Takara Bio Europe, Gothenburg, Sweden |
|
| Lecture hall G | Supporter (Chair: Dirk Strunk) | |
| 11:00 – 11:05 | Introduction | |
| 11:05 – 11:35 | C4 – Generation of dopaminergic precursor cells and terminally differentiated neurons from human pluripotent cells for drug discovery and cell therapy Mohan C Vemuri, Thermo Fisher Scientific, Frederick, U.S.A. |
|
| 11:35 – 12:05 | C5 – Enabling GMP-compliant iPSC expansion and differentiation on the CliniMACS® Prodigy platform Sebastian Knöbel, Miltenyi Biotec GmbH, Bergisch Gladbach |
|
| 12:05 – 12:35 | C6 – Using Pluripotent Stem Cells in the Age of Genome Editing Theresa Dsouza, R&T Lonza Bioscience, Cologne |
|
| Lecture hall M | Supporters (Chair: Michael Rieger) | |
| 11:00 – 11:05 | Introduction | |
| 11:05 – 11:35 | C7 – Translation of cell-based gene therapy into clinical application Elena Meurer, apceth GmbH & Co. KG, Munich |
|
| 11:35 – 12:05 | C8 – Simultaneous single-molecule quantification of DNA, RNAs & Proteins Maik Pruess, Nanostring Technologies, Hamburg |
|
| 12:05 – 12:35 | C9 – STEMdiff™ Kits for Robust and Efficient Differentiation of Human Pluripotent Stem Cells Katharina Debowski, Stem Cell Technologies SARL, Cologne |
|
| Lecture hall N |
Satellitensymposium “Totipotente Nicht-Embryonen und nicht-totipotente Embryonen” |
|
| 11:00 – 18:15 |
open to GSCN participants Program (in german) |
|
| 12:35 – 14:00 | Lunch buffet/industry exhibition/poster viewing | |
| 12:45 – 13:45 | Meet-the-expert tables (Bistro/ground floor): Ingo Roeder (Bioinformatic analysis of biological data), Hans Schöler and Ana Martin-Villalba (limited to 10 registered participants each) |
|
| Lecture hall F |
Presidential Symposium (Chair: Ulrich Martin) | |
| 14:00 – 14:30 |
PS1 – Engineered human heart muscles for disease modelling and cardiac repair Thomas Eschenhagen, UKE, Hamburg |
|
| 14:30 – 15:00 | Young Investigator Award 2016 PS2 – Developmental programming by lncRNA-TF pairs during the induction of the embryonic heart Leo Kurian, University of Cologne |
|
| 15:00 – 15:30 |
Female Scientist Award 2016 PS3 – Generation and regeneration of human and murine hematopoietic stem cells Claudia Waskow, TU Dresden |
|
| 15:30 – 16:00 | Publication of the Year 2016 Award (June 2015 – 2016) PS4 – Direct reprogramming of hepatic myofibroblasts into hepatocytes in vivo attenuates liver fibrosis Guanqgi Song, Hannover Medical School |
|
| 16:00 – 16:30 |
Coffee break/industry exhibition |
|
| 16:30 – 18:30 | Poster session II: P078 – P147 P078 – P091: Tissue engineering and organoids P092 – P097: Genome engineering and gene therapy P098 – P119: Stem cells in regenerative therapies P120 – P124: Stem cells in regenerative therapies: mesenchymal stem/stroma cells P125 – P147: Stem cells in disease modeling and drug development Even numbers: please present your poster from 16:30 – 17:30 Odd numbers: 17:30 – 18:30 |
|
| 18:30 – 19:00 | Bus transfer | |
| 19:00 – 01:00 |
GSCN Networking evening for all participants with dinner buffet and DJ at the Yukon Bay, Hannover Zoo |
|
Top |
Wednesday, 14 September
| Concurrent scientific working group session III | ||
| Lecture hall H |
Somatic stem cells and development (Chairs: Ana Martin Villalba/Thomas Braun) | |
| 09:00 – 09:15 | Overview Jan Lohmann, Centre of Organismal Studies, Heidelberg University |
|
| 09:15 – 09:30 | T36 – Fate-restriction precedes stemness during massive post-embryonic growth in the fish branchia Lazaro Centanin, Centre of Organismal Studies, Heidelberg University |
|
| 09:30 – 09:45 | T37 – Visualization of stem cell induction and differentiation in real time Rasmus Freter, University of Oxford |
|
| 09:45 – 10:00 | T38 – Embryo-derived macrophages regulate the dendritic cell pool size in the adult spleen Gulce Percin, TU Dresden |
|
| 10:00 – 10:15 | T39 – A role for YAP and TAZ signaling in human neural crest development Alexandra Larisa Condurat, Freiburg University |
|
| 10:15 – 10:30 | Working group discussion | |
| Lecture hall G | Stem cells in reg. therapies II (Chairs: Richard Schäfer/Dirk Strunk) | |
| 09:00 – 09:15 | Overview Karen Bieback, Medical Faculty Mannheim, Heidelberg University |
|
| 09:15 – 09:30 | T40 – Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells Cornelia Scharler, Paracelsus Private Medical University of Salzburg, Austria |
|
| 09:30 – 09:45 | T41 – Cryopreserved or fresh mesenchymal stromal cells: only a matter of taste or key to unleash the full clinical potential of MSC therapy? Guido Moll, Charite Berlin |
|
| 09:45 – 10:00 | T42 – Synthetic niche to modulate regenerative potential of mesenchymal stromal cells (MSCs) and enhance skeletal muscle regeneration Sven Geißler, Charite Berlin |
|
| 10:00 – 10:15 | T43 – Extracellular vesicles – From bench to bedside Verena Börger, University Hospital Essen |
|
| 10:15 – 10:30 | Working group discussion | |
| Lecture hall N |
Stem cells in diseases: cancer stem cells(Chairs: Thomas Brabletz/Andreas Trumpp) |
|
| 09:00 – 09:20 | Overview Andreas Trumpp, German Center Reserach Center, Heidelberg |
|
| 09:20 – 09:40 | T44 – ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types Julia Kleemann, University of Erlangen-Nuremberg |
|
| 09:40 – 10:00 | T45 – Heterotrimeric G-proteins are indispensable for FLT3-ITD autophosphorylation and oncogenic function Michael Rieger, Goethe University Hospital and LOEWE Center Frankfurt |
|
| 10:00 – 10:15 | T46 – A mathematical model approach to study the immunological effects in CML patients during and after TKI treatment Ingmar Glauche, TU Dresden |
|
| 10:15 – 10:30 | Working group discussion | |
| 10:30 – 11:00 |
Coffee break/industry exhibition | |
| Concurrent strategic working group session |
||
| Lecture hall H |
Technologies in stem cell research (Chairs: Frank Emmrich/Andreas Bosio) | |
| 11:00 – 11:25 | S1 – Intestinal epithelial organoids – an accessible model for mammalian stem cell niche biology Henner Farin, Georg-Speyer-Haus, Frankfurt |
|
| 11:25 – 11:50 | S2 – 3D bioartificial cardiac tissue from pluripotent stem cells Ina Gruh, REBIRTH, Hannover Medical School |
|
| 11:50 – 12:15 | S3 – Using cerebral organoids for studying human disease modeling and lineage reprogramming Marissa Karow, LMU Munich |
|
| 12:15 – 12:30 | Panel discussion | |
| Lecture hall G | Career development and funding opportunities (Chairs: Insa Schröder/Hartmut Geiger) | |
| 11:05 – 11:40 | S4 – Career paths for scientists – suitable application strategies Anke Raloff, ZEIT Verlagsgruppe/ACADEMICS |
|
| 11:40 – 12:15 | S5 – tba tbc |
|
| 12:15 – 12:30 | Panel discussion | |
| Lecture hall N |
Clinical trials and regulatory affairs (Chairs: Torsten Tonn/Andreas Kurtz) |
|
| 11:00 – 11:25 | S6 – Investigator initiated trials (IIT) of advanced therapy medicinal products Felipe Prosper, University Clinic Navarra, Pamplona, Spain |
|
| 11:25 – 11:50 | S7 – EU research perspective on advanced therapies Arnd Hoeveler, European Commission, Brussels |
|
| 11:50 – 12:15 | S8 – Mapping the European landscape for patenting stem cell related inventions Aliki Nichogiannopoulou, European Patent Office, Munich |
|
| 12:15 – 12:30 | Panel discussion | |
| 12:30 – 14:00 |
Lunch buffet/industry exhibition/poster viewing |
|
| 12:45 – 13:45 | Meet-the-expert tables (Bistro/ground floor): Marisa Karow (Cerebral organoids), Henner Farin (Intestinal epithelial organoids) and Ina Gruh (3D bioartificial cardiac tissue) register at the registration desk (limited to 10 registered participants each) | |
| Lecture Hall F | Joined session with Rebirth/Hannover Medical School (MHH) | |
| 14:00 – 14:45 |
Keynote lecture IV K4 – Patterning mesoderm and blood development from human pluripotent stem cells Peter Zandstra, University of Toronto, Canada (Chair: Karl Lenhard Rudolph) |
|
| 14:45 – 15:30 |
Keynote lecture V K5 – Stemming vision loss using stem cells – seeing is believing Pete Coffey, University College London, U.K. (Chair: Thomas Braun ) |
|
| 15:30 – 15:45 | GSCN Outlook 2017 Incoming president: Karl Lenhard Rudolph |
|
| 15:45 – 16:15 |
Coffee break/industry exhibition | |
| Lecture hall F | Rebirth Session (Chairs: Ulrich Martin/Tobias Cantz) | |
| 16:15 – 16:35 | RB1 – From cell to product: governance issues along the translational pathway Nils Hoppe, CELLS – Centre for Ethics and Law in the Life Sciences, Leibniz University Hannover |
|
| 16:35 – 16:55 | RB2 – Emerging protein- and small molecule-based therapies for cardiac repair Kai Wollert, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School |
|
| 16:55 – 17:15 | RB3 – Therapeutic noncoding RNA based approaches of heart failure Thomas Thum, Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School |
|
| 17:15 – 17:35 | RB4 – Manufacturing human pluripotent stem cells and their progenies Robert Zweigerdt, Hannover Medical School |
|
| Lecture hall F | Closing ceremony | |
| 17:35 – 17:50 | Poster award ceremony and announcement of industry quiz winners (Daniel Besser; GSCN) supported by PeproTech GmbH |
|
| End of GSCN conference 2016 |
||
| Announcement: | ||
| 19:00 – 21:00 | GSCN Public outreach event with panelists (in German) Moderne Zelltherapien – Stammzellen bei Herz- und Lebererkrankungen Podiumsdiskussion und Kurzfilme |
|
| Podiumsgäste: Prof Dr. Axel Haverich, Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie, MHH Prof. Dr. Ulrich Martin, Leibniz Forschungs- laboratorien für Biotechnologie und künstliche Organe , MHH Prof. Dr. Michael Manns, Klinik für Gastroenterologie, Hepatologie und Endokrinologie, MHH Prof. Dr. Nils Hoppe, Centre for Ethics and Law in the Life Sciences Hannover, LUH Moderation: Dr. Stefanie Seltmann, DKFZ Heidelberg |
||
Top |
© German Stem Cell Network (GSCN) e.V., 2016
Last updated 29/01/2016, Powered by Webdesigner Berlin
Last updated 29/01/2016, Powered by Webdesigner Berlin


















